Reading:
COVID-19 and Asthma in Children

COVID-19 and Asthma in Children

June 21, 2021

Written by Bhaskar Paliwal, Jyotsna Mehta

Is your asthmatic child more susceptible to coronavirus? Should you take your child to scheduled medical appointments? Is asthma a risk factor for COVID-19 infection in children? Does the intensity or control of asthma affect the disease progression? Are asthma treatments beneficial or harmful? Every parent of an asthmatic child has plenty of other unanswered questions.

The current global COVID-19 caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus outbreak started from Wuhan, began in or around December 2019. COVID-19 was declared a pandemic health emergency by the World Health Organization on January 30th, 2020. However, COVID-19 has continued to spread rapidly since then, and it is now the most severe pandemic in 100 years.

No significant evidence has been observed on pediatric asthma as a comorbidity for COVID-19 after looking at several studies to see how the COVID-19 affects the pediatric population with asthma. The first published pediatric case was in January 2020; the patient was a 10year old kid from Shenzhen, China, whose family had visited Wuhan. So far, all epidemiological evidence indicates that SARS-Co V-2 infection in children is less severe than in adults. Only 239 (2%) of the 16,749 patients hospitalized for COVID-19 in the UK’s most recent and most significant research were under 18. According to Chinese guidelines, “Children with a history of contact with severe 2019-nCoV infected cases, or with underlying conditions such as congenital heart disease, bronchial pulmonary hypoplasia, respiratory tract anomaly, with abnormal hemoglobin level, severe malnutrition, or with immune deficiency or immunocompromised status… may become severe cases.”

A study carried out by Nicholas M. MD, MPH; Massachusetts general hospital highlighted some unexpected risks COVID-19 has on Asthma control in children. Due to the pandemic, many medical practices are limited to tele-health visits. As a result, tele-health offers immediate access to health care and decreases ER visits following the pandemic. By implementing social distancing and stay-at-home orders, children are no longer exposed to viruses from other children that can cause respiratory illnesses resulting in exacerbating asthma.

The primary studies to date have only reported the number of cases by age group; thus, it is unclear whether COVID-19 risk or severity is linked to childhood asthma or other pediatric respiratory disorders.

About Keva Health

Keva Health’s platform is integrating innovative remote monitoring functionality with evidence based self-monitoring programs for patients with chronic respiratory diseases to improve outcomes and reduce cost. Please contact us at [email protected] for more info.

 



0 Comments

Leave a Reply

Related Stories

February 19, 2022

Webinar – Pediatric Remote Patient Monitoring for Respiratory Illness

View the Webinar for FREE

A discussion about the importance of pediatric remote patient monitoring for respiratory illness

smoking
November 14, 2023

Quitting Early: Cessation Tips for Young Adults

Smoking cigarettes is a common issue. According to research, it is more difficult to quit smoking when your body has been relying on this foreign stimulus for a long time. This research published in Addiction in 2021 monitored thousands of smokers between 2002 and 2014 and found that younger users are more likely to successfully quit for at least 30 days of abstinence. That’s because older users are more likely to smoke heavily and may thus be less encouraged to make quit attempts. Cessation is always a challenging process, but an earlier quit attempt increases one’s chances for success. In this article, we go over a few cessation tips to help young adults in this journey.

December 6, 2021

Webinar – New Frontiers in Digital Health

Schedule a consultation call to learn more

A discussion focused on the positive influence tech is having on patients, caregivers, providers, and insurers. Hear from these industry leaders on the new insights on digital health technology, investments, & translation to patient care.

Arrow-up

Reg CF Disclaimer

No money or other consideration is being solicited, and if sent in response, will not be accepted. No offer to buy the securities can be accepted and no part of the purchase price can be received until the offering statement is filed and only through an intermediary’s platform. An indication of interest involves no obligation or commitment of any kind. “reserving” securities is simply an indication of interest.